By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911


SEARCH JOBS


Industry
Biotechnology






Company News
Celldex Therapeutics, Inc. (CLDX) Announces Publication Of Glembatumumab Vedotin Phase 1/2 Studies In The Journal Of Clinical Oncology 9/30/2014 9:14:10 AM
Celldex Therapeutics, Inc. (CLDX) Initiates Pilot Study Of CDX-301 In Allogeneic Hematopoietic Stem Cell Transplantation 9/25/2014 8:25:28 AM
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation At The Morgan Stanley (MST) Healthcare Conference 9/4/2014 7:55:53 AM
Celldex Therapeutics, Inc. (CLDX) Reports Second Quarter 2014 Results 8/6/2014 4:29:53 PM
Celldex Therapeutics, Inc. (CLDX) Announces Senior Leadership Promotions 7/30/2014 10:43:37 AM
Celldex Therapeutics, Inc. (CLDX) To Report Second Quarter 2014 Financial Results And Host Corporate 2014 Objectives Update Call 7/18/2014 6:35:18 AM
Oncothyreon Inc. (ONTY) And Celldex Therapeutics, Inc. (CLDX) Announce Collaboration For Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab 5/29/2014 9:52:32 AM
Celldex Therapeutics, Inc. (CLDX) Announces Varlilumab (CDX-1127) Phase 1 Clinical Data To Be Presented At American Society of Clinical Oncology Annual Meeting 2014 5/14/2014 3:06:58 PM
Bristol-Myers Squibb Company (BMY) And Celldex Therapeutics, Inc. (CLDX) Announce Clinical Trial Collaboration To Evaluate The Combination Of Investigational Immunotherapies Nivolumab And Varlilumab 5/14/2014 8:34:17 AM
Celldex Therapeutics, Inc. (CLDX) To Present Antibody-Drug Conjugate CDX-014 Preclinical Proof Of Concept Data At American Association for Cancer Research 2014 4/3/2014 12:08:25 PM
12345678910...
//-->